AbbVie announced that the independent directors of the board have selected Roxanne Austin as lead independent director, effective July 1, 2024. Ms. Austin succeeds Glenn F. Tilton, who has served as lead independent director since 2013. Mr. Tilton will continue to serve…
Biogen today announced the appointment of Monish Patolawala, currently President and CFO of 3M, to the Company’s Board of Directors, effective January 1, 2024. As an accomplished financial executive, Mr. Patolawala is qualified as an Audit Committee financial expert and…
Bristol Myers Squibb announced that its Board of Directors has unanimously elected Christopher Boerner, Ph.D., to serve as Chair of the Board, effective April 1, 2024. He succeeds Giovanni Caforio, M.D., who will step down as Chair of the Board…